Dual Functional Eudragit ® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside f...
Dual Functional Eudragit ® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis
About this item
Full title
Author / Creator
Gao, Chenzhe , Yu, Shen , Zhang, Xiaonan , Dang, Yanxin , Han, Dan-Dan , Liu, Xin , Han, Janchun and Hui, Mizhou
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Iridoid glycosides (IG) as the major active fraction of
Lindl. has a proven anti-inflammatory effect for ulcerative colitis (UC). However, its current commercial formulations are hampered by low bioavailability and unable to reach inflamed colon. To overcome the limitation, dual functional IG-loaded nanoparticles (DFNPs) were prepared to increas...
Alternative Titles
Full title
Dual Functional Eudragit ® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_72a1756fac7342e58ada008ae15097f8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_72a1756fac7342e58ada008ae15097f8
Other Identifiers
ISSN
1178-2013,1176-9114
E-ISSN
1178-2013
DOI
10.2147/IJN.S291090
